These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 28017442)
21. Who Neglects Neglected Tropical Diseases? - Korean Perspective. Choi MH; Yu JR; Hong ST J Korean Med Sci; 2015 Nov; 30 Suppl 2(Suppl 2):S122-30. PubMed ID: 26617444 [TBL] [Abstract][Full Text] [Related]
22. Vaccines against poverty. MacLennan CA; Saul A Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12307-12. PubMed ID: 25136089 [TBL] [Abstract][Full Text] [Related]
23. Effective vaccine safety systems in all countries: a challenge for more equitable access to immunization. Amarasinghe A; Black S; Bonhoeffer J; Carvalho SM; Dodoo A; Eskola J; Larson H; Shin S; Olsson S; Balakrishnan MR; Bellah A; Lambach P; Maure C; Wood D; Zuber P; Akanmori B; Bravo P; Pombo M; Langar H; Pfeifer D; Guichard S; Diorditsa S; Hossain MS; Sato Y Vaccine; 2013 Apr; 31 Suppl 2():B108-14. PubMed ID: 23598471 [TBL] [Abstract][Full Text] [Related]
24. New vaccine introduction in the East and Southern African sub-region of the WHO African region in the context of GIVS and MDGs. Chauke-Moagi BE; Mumba M Vaccine; 2012 Sep; 30 Suppl 3():C3-8. PubMed ID: 22939018 [TBL] [Abstract][Full Text] [Related]
25. New Vaccines for the World's Poorest People. Hotez PJ; Bottazzi ME; Strych U Annu Rev Med; 2016; 67():405-17. PubMed ID: 26356803 [TBL] [Abstract][Full Text] [Related]
26. Achieving a "Grand Convergence" in global health by 2035. Mahmoud A Vaccine; 2017 Jan; 35 Suppl 1():A2-A5. PubMed ID: 28012780 [TBL] [Abstract][Full Text] [Related]
28. Poverty-related and neglected diseases - an economic and epidemiological analysis of poverty relatedness and neglect in research and development. von Philipsborn P; Steinbeis F; Bender ME; Regmi S; Tinnemann P Glob Health Action; 2015; 8():25818. PubMed ID: 25623607 [TBL] [Abstract][Full Text] [Related]
29. Double burden of noncommunicable and infectious diseases in developing countries. Bygbjerg IC Science; 2012 Sep; 337(6101):1499-501. PubMed ID: 22997329 [TBL] [Abstract][Full Text] [Related]
31. Bridging the gap: need for a data repository to support vaccine prioritization efforts. Madhavan G; Phelps C; Sangha K; Levin S; Rappuoli R Vaccine; 2015 Jun; 33 Suppl 2(0 2):B34-9. PubMed ID: 26022565 [TBL] [Abstract][Full Text] [Related]
32. The global fight to develop antipoverty vaccines in the anti-vaccine era. Hotez PJ Hum Vaccin Immunother; 2018; 14(9):2128-2131. PubMed ID: 29393710 [TBL] [Abstract][Full Text] [Related]
33. Delivering vaccines to the people who need them most. Barocchi MA; Rappuoli R Philos Trans R Soc Lond B Biol Sci; 2015 Jun; 370(1671):. PubMed ID: 25964460 [TBL] [Abstract][Full Text] [Related]
34. Meeting of the Strategic Advisory Group of Experts on immunization, April 2013 – conclusions and recommendations. Wkly Epidemiol Rec; 2013 May; 88(20):201-6. PubMed ID: 23696983 [No Abstract] [Full Text] [Related]
35. Influence of disease burden, public perception, and other factors on new vaccine development, implementation, and continued use. Levine MM; Levine OS Lancet; 1997 Nov; 350(9088):1386-92. PubMed ID: 9365466 [TBL] [Abstract][Full Text] [Related]
36. Vaccines and global health. Greenwood B; Salisbury D; Hill AV Philos Trans R Soc Lond B Biol Sci; 2011 Oct; 366(1579):2733-42. PubMed ID: 21893534 [TBL] [Abstract][Full Text] [Related]
37. The Vast and Varied Global Burden of Norovirus: Prospects for Prevention and Control. Lopman BA; Steele D; Kirkwood CD; Parashar UD PLoS Med; 2016 Apr; 13(4):e1001999. PubMed ID: 27115709 [TBL] [Abstract][Full Text] [Related]
38. Working to overcome the global impact of neglected tropical diseases – Summary. Wkly Epidemiol Rec; 2011 Mar; 86(13):113-20. PubMed ID: 21438440 [No Abstract] [Full Text] [Related]
39. Policy analysis: an essential research tool for the introduction of vaccines in developing countries. Mahoney R J Health Popul Nutr; 2004 Sep; 22(3):331-7. PubMed ID: 15609786 [TBL] [Abstract][Full Text] [Related]
40. Vaccines and biologicals. Part II. Recommendations from the Strategic Advisory Group of Experts. Strategic Advisory Group of Experts (SAGE) Wkly Epidemiol Rec; 2001 Dec; 76(49):386-8. PubMed ID: 11775289 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]